Revance Therapeutics, Inc.
Nashville, TN Doing business as Revance Revance Therapeutics, Inc.
- UEI
- HY78DQBTLLG3
- CAGE
- 9QP59
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 1222 Demonbreun St Suite 2000, Nashville, TN 37203, USA
- Website
- revance.com
- Founded
- 1999
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Quick answers
What is Revance Therapeutics, Inc.'s UEI?
Revance Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is HY78DQBTLLG3.
What is Revance Therapeutics, Inc.'s CAGE code?
Revance Therapeutics, Inc.'s CAGE code is 9QP59.
What is Revance Therapeutics, Inc.'s primary NAICS code?
Revance Therapeutics, Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Revance Therapeutics, Inc. located?
Revance Therapeutics, Inc.'s physical address in SAM.gov is 1222 Demonbreun St Suite 2000, Nashville, TN 37203, USA.
Is Revance Therapeutics, Inc. registered in SAM.gov?
Yes. Revance Therapeutics, Inc.'s SAM.gov registration is active through April 29, 2027.
Which contract vehicles does Revance Therapeutics, Inc. hold?
Revance Therapeutics, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
On GovTribe
See Revance Therapeutics, Inc.'s full federal record
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors